Assistant Professor, Radiological Sciences, UCLA School of Medicine

Radiology

Dr. Whitney Pope practices Radiology. He went to medical school at University of Illinois College of Medicine. Whitney Pope is a published MD. He has 34 papers published. The most current publication "Immunotherapy response assessment in neuro-oncology: a report of the RANO working group." He is registered with Medicare and accepts Medicare payments.

Publications

---

• pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI.
• Evidence for rCBV as an early response marker following bevacizumab treatment.
• Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.
• MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab.
• Between-Scanner and Between-Visit Variation in Normal White Matter Apparent Diffusion Coefficient Values in the Setting of a Multi-Center Clinical Trial.
• Nitroxoline induces apoptosis and slows glioma growth in vivo.
• Relationship Between [(18)F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
• Arterial Spin-Labeling Perfusion MRI Stratifies Progression-Free Survival and Correlates with Epidermal Growth Factor Receptor Status in Glioblastoma.
• Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
• A novel bicompartmental mathematical model of glioblastoma multiforme.
• Facing the future of brain tumor clinical research.
• Emerging techniques and technologies in brain tumor imaging.
• Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).
• Intraoperative mass spectrometry of tumor metabolites.
• Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.
• Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry.
• C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma.
• Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastoma.
• Short-interval estimation of proliferation rate using serial diffusion MRI predicts progression-free survival in newly diagnosed glioblastoma treated with radiochemoth...
• Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicent...
• Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI.
• Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma.
• Ensemble segmentation for GBM brain tumors on MR images using confidence-based averaging.
• Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images.
• Probabilistic radiographic atlas of glioblastoma phenotypes.
• Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.
• Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy.
• Imaging biomarkers for antiangiogenic therapy in malignant gliomas.
• Primary central nervous system histiocytic sarcoma presenting as a postradiation sarcoma: case report and literature review.
• Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma.
• Functionalized Magnetonanoparticles in Visualization of Intracranial Tumors on MRI.
• Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging.
• The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab.

Schools

---

• University Of Illinois College Of Medicine Chicago

• West La Va Med Center

• University Of California Los Angeles

Doctors Specialties

---

• Neuroradiology
• Radiology

Accepted Insurances

---

Education

---

• UCLA Medical Center
• VA Greater Los Angeles Healthcare System
• University of Illinois College of Medicine

Hospital

---

• Ronald Reagan UCLA Medical Center
• Santa Monica-UCLA Medical Center and Orthopaedic Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Dennis E. Der, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert Cohen, MD
	Dr. John P. Grimm, MD This Doctor is OpenDoctor Recommended.
	Dr. Hazem H. Hosein, MD This Doctor is OpenDoctor Recommended.
	Dr. Gerald J. Kavanagh, MD
	Dr. Laura R. Doepke, MD This Doctor is OpenDoctor Recommended.
	Dr. Stephen W. Metting, MD This Doctor is OpenDoctor Recommended.
	Dr. Christopher Y. Kwun, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog